Zurich North America Launches New Specialties Business and CDM Units
January 17, 2025 - 14:26
In a significant move to enhance its operational efficiency, Zurich North America has announced the creation of a new specialties business and the establishment of its Customer Development and Management (CDM) units. This restructuring initiative is a key component of the company’s comprehensive three-year strategic plan aimed at driving growth and improving customer service.
The new specialties business is designed to focus on niche markets, allowing Zurich to tailor its offerings to meet the specific needs of various industries. By concentrating resources on specialized sectors, the company aims to foster deeper client relationships and provide more customized solutions.
Additionally, the formation of the CDM units underscores Zurich's commitment to enhancing customer engagement and support. These units will be instrumental in developing strategies that prioritize customer satisfaction and streamline communication between the company and its clients.
This restructuring is expected to position Zurich North America for sustained success in a competitive landscape, ensuring it remains responsive to the evolving demands of the market.
MORE NEWS
May 16, 2026 - 00:10
Blake's Snow Shack owned by man with Down syndrome in Texas turns 10In the small North Texas town of Sanger, a beloved local business is marking a sweet anniversary. Blake`s Snow Shack, a shaved ice stand owned and operated by a man with Down syndrome, is turning...
May 15, 2026 - 04:31
SBA Launches Small Business Pitch Competition » CBIAThe U.S. Small Business Administration has announced a new pitch competition aimed at companies that show strong innovation and have a track record of using SBA-backed financing tools. The contest...
May 14, 2026 - 01:02
INOVIO Reports First Quarter 2026 Financial Results and Recent Business HighlightsINOVIO has released its financial results for the first quarter of 2026, alongside a summary of recent business developments. The company`s primary focus remains on the regulatory path for its lead...
May 13, 2026 - 04:15
Curis Provides First Quarter 2026 Business UpdateCuris, Inc., a biotechnology company advancing the development of its lead drug candidate emavusertib, provided a business update for the first quarter of 2026. The company is focused on...